141 related articles for article (PubMed ID: 1847982)
1. Induction of erythropoietin receptors during aclacinomycin-mediated erythroid differentiation of K562 leukemia cells.
Jeannesson P; Trentesaux C; Nyoung MN; Mayeux P; Jacquot R; Jardillier JC
Leukemia; 1991 Jan; 5(1):14-8. PubMed ID: 1847982
[TBL] [Abstract][Full Text] [Related]
2. Induction of the receptor for erythropoietin in murine erythroleukemia cells after dimethyl sulfoxide treatment.
Tojo A; Fukamachi H; Saito T; Kasuga M; Urabe A; Takaku F
Cancer Res; 1988 Apr; 48(7):1818-22. PubMed ID: 2832053
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells.
Trentesaux C; Nyoung MN; Aries A; Morceau F; Ronchi A; Ottolenghi S; Jardillier JC; Jeannesson P
Leukemia; 1993 Mar; 7(3):452-7. PubMed ID: 8445949
[TBL] [Abstract][Full Text] [Related]
4. Effect of aclacinomycin-doxorubicin association on differentiation and growth of human erythroleukemic K562 cells.
Nyoung MN; Trentesaux C; Aries A; Carpentier Y; Jardillier JC; Gorisse MC; Jeannesson P
Anticancer Res; 1994; 14(3A):1203-8. PubMed ID: 8074473
[TBL] [Abstract][Full Text] [Related]
5. Binding of iodinated erythropoietin to rat bone marrow cells under normal and anemic conditions.
Akahane K; Tojo A; Fukamachi H; Kitamura T; Saito T; Urabe A; Takaku F
Exp Hematol; 1989 Feb; 17(2):177-82. PubMed ID: 2536329
[TBL] [Abstract][Full Text] [Related]
6. Specific binding of erythropoietin to its receptor on responsive mouse erythroleukemia cells.
Todokoro K; Kanazawa S; Amanuma H; Ikawa Y
Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4126-30. PubMed ID: 3035570
[TBL] [Abstract][Full Text] [Related]
7. Expression and modulation of specific, high affinity binding sites for erythropoietin on the human erythroleukemic cell line K562.
Fraser JK; Lin FK; Berridge MV
Blood; 1988 Jan; 71(1):104-9. PubMed ID: 2825843
[TBL] [Abstract][Full Text] [Related]
8. Expression of high affinity receptors for erythropoietin on human bone marrow cells and on the human erythroleukemic cell line, HEL.
Fraser JK; Lin FK; Berridge MV
Exp Hematol; 1988 Nov; 16(10):836-42. PubMed ID: 2844573
[TBL] [Abstract][Full Text] [Related]
9. Identification of the erythropoietin receptors of erythroleukemic cells.
Wang FF; Wang YJ; Lee HJ; Fong JC
Biochem Int; 1989 Jan; 18(1):163-71. PubMed ID: 2541719
[TBL] [Abstract][Full Text] [Related]
10. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
[TBL] [Abstract][Full Text] [Related]
11. Down-modulation of high-affinity receptors for erythropoietin on murine erythroblasts by interleukin 3.
Fraser JK; Nicholls J; Coffey C; Lin FK; Berridge MV
Exp Hematol; 1988 Oct; 16(9):769-73. PubMed ID: 2844574
[TBL] [Abstract][Full Text] [Related]
12. Cooperative effects of hemin and anthracyclines in promoting terminal erythroid maturation in K562 human erythroleukemia cells.
Tsiftsoglou AS; Wong W; Tsamadou AI; Robinson SH
Exp Hematol; 1991 Oct; 19(9):928-33. PubMed ID: 1893971
[TBL] [Abstract][Full Text] [Related]
13. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, inhibits erythropoietin-induced erythroid differentiation of K562 cells.
Kubota Y; Tanaka T; Yamaoka G; Yamaguchi M; Ohnishi H; Kawanishi K; Takahara J; Irino S
Leukemia; 1996 Apr; 10(4):720-6. PubMed ID: 8618453
[TBL] [Abstract][Full Text] [Related]
14. Expression of specific high-affinity binding sites for erythropoietin on rat and mouse megakaryocytes.
Fraser JK; Tan AS; Lin FK; Berridge MV
Exp Hematol; 1989 Jan; 17(1):10-6. PubMed ID: 2535696
[TBL] [Abstract][Full Text] [Related]
15. Nuclear transcription factor GATA-1 is activated during aclacinomycin-induced erythroid differentiation.
Gillet R; Bobichon H; Trentesaux C
Biol Cell; 2002 Sep; 94(4-5):267-73. PubMed ID: 12489695
[TBL] [Abstract][Full Text] [Related]
16. Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells.
Morceau F; Aries A; Lahlil R; Devy L; Jardillier JC; Jeannesson P; Trentesaux C
Biochem Pharmacol; 1996 Mar; 51(6):839-45. PubMed ID: 8602880
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha inhibits aclacinomycin A-induced erythroid differentiation of K562 cells via GATA-1.
Morceau F; Schnekenburger M; Blasius R; Buck I; Dicato M; Diederich M
Cancer Lett; 2006 Aug; 240(2):203-12. PubMed ID: 16274927
[TBL] [Abstract][Full Text] [Related]
18. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
Taniguchi S; Dai CH; Krantz SB
Exp Hematol; 1997 Mar; 25(3):193-8. PubMed ID: 9091293
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional and posttranscriptional regulation of erythroid gene expression in anthracycline-induced differentiation of human erythroleukemic cells.
Morceau F; Chénais B; Gillet R; Jardillier JC; Jeannesson P; Trentesaux C
Cell Growth Differ; 1996 Aug; 7(8):1023-9. PubMed ID: 8853898
[TBL] [Abstract][Full Text] [Related]
20. Internalization of radioiodinated erythropoietin and the ligand-induced modulation of its receptor in murine erythroleukemia cells.
Fukamachi H; Tojo A; Saito T; Kitamura T; Nakata M; Urabe A; Takaku F
Int J Cell Cloning; 1987 May; 5(3):209-19. PubMed ID: 3474303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
